Lung cancer causes many deaths because most cases are found late. When cancer is found early, treatments work better and patients have a better chance to live longer. Early detection also helps lower medical costs by treating the disease sooner. But less than six percent of people who should get tested in the U.S. actually do. Many issues cause this low number. These include not having easy access to tests, patients not following through, and hard-to-read test results.
AI is helping to change how early lung cancer detection works. Places like Massachusetts General Hospital’s AI research center and companies like GE HealthCare and Optellum are developing new AI tools. These tools help doctors find lung cancer earlier and more accurately.
CT scans are very important for finding early lung cancer. About 30 percent of chest CT scans show small spots called nodules that might be cancer. It can be hard to tell if these nodules are cancerous or not. Expert doctors need to look carefully.
GE HealthCare and Optellum have worked together to make an AI system called the Virtual Nodule Clinic. It uses many CT scans from around the world to teach itself. The AI can quickly check nodules and give a score from 1 to 10 that shows if nodules look dangerous. A higher score means more risk.
This helps doctors to decide which patients need urgent care and which do not. The system also reduces mistakes and saves time for doctors. It works for patients getting lung cancer screening and also those who have scans for other reasons but have nodules found by chance.
Other AI tools use detailed models like convolutional neural networks (CNNs) to tell if a nodule is cancer or not. Some of these models include Faster R-CNN, CMixNet, and 3D CNN. They have shown they can correctly detect cancer over 94 percent of the time. They can classify nodules with around 95 percent accuracy.
This high accuracy is important. It helps stop unnecessary biopsies and treatments for patients who do not have cancer. It also helps doctors catch cancer early when treatment works best. These AI models keep getting better by learning with new patient data. Hospitals using these tools can improve their testing process and offer fair care to all patients.
Massachusetts General Hospital’s AI center is also working on ways to watch patients after lung surgery. They use AI with data from wearable devices that track heart rate, oxygen levels, and movement in real time.
The AI can warn doctors if a patient’s health gets worse after leaving the hospital. This early warning helps prevent serious problems and keeps patients safer. Hospitals can save money and improve care by using this kind of monitoring.
New research shows lung cancer might be found by listening to changes in a person’s voice. AI models like Graph Attention Transformer Fine-Tuning Contrastive Learning (GAT-ftCL) can pick up small voice changes that people cannot hear.
One study found this method found lung cancer patients with about 91 percent accuracy. It was even better at finding early-stage cancer, about 93 percent accurate. The AI uses features like Mel Frequency Cepstral Coefficients (MFCC) from speech to study lung health.
This way of testing is easy and does not require machines like CT scanners. It can be done on phones or over video calls, making it good for rural places that have fewer medical resources.
Many important organizations give money to develop AI tools for lung cancer detection. The National Institutes of Health (NIH) and the Prevent Cancer Foundation are two of them. For example, Dr. Mohammadhadi Khorrami at Emory University got a $100,000 grant to build better AI imaging tools.
The Prevent Cancer Foundation is investing $20 million to support new detection technologies. Their goal is to lower cancer deaths by 40 percent by 2035. They also want to make sure that people in underserved communities get help from these new tools.
This funding shows AI is becoming part of cancer care. Hospital leaders and IT managers should keep track of this work for possible future partnerships and new tools.
Lung cancer screening needs good teamwork between doctors, radiology, and patients. AI phone systems can help by managing appointments, sending reminders, and handling pre-screening questions. This reduces mistakes and helps patients follow their screening schedule better.
AI workflow tools can send test results and risk scores to the right specialists automatically. They can also give alerts for clinical decisions based on set rules. This makes communication faster and helps patients get care quicker.
AI systems like Simbo AI can help with post-surgery care by managing automated check-in calls and symptom tracking. Combined with data from wearable devices, these tools let doctors respond quickly if problems happen after surgery.
Using automation for routine tasks frees up staff to focus more on patient care. Clinics can use their nursing and office workers better and improve record keeping. This leads to better care and happier patients.
Healthcare leaders in the U.S. need cost-effective lung cancer detection that fits with quality rules and insurance policies. Early detection is part of value-based care, which focuses on good results and managing patients quickly.
Using AI tools means hospitals must invest in technology, training, and changing workflows. But this can lead to fewer late-stage cancer cases, lower costs, and better patient experience. Combining AI with patient communication tools can create a strong system for lung cancer care.
Lung cancer remains a serious health problem. New AI tools, supported by research money, offer ways to improve early screening and diagnosis across the country. Careful planning by medical and IT leaders is needed to use these tools well.
In summary, using AI in lung cancer imaging, diagnosis, and workflows offers a way to improve early detection in the United States. Medical managers and IT staff should watch these new technologies and think about adding them to their care programs to help patients and improve safety.
The mission of the Center for Artificial Intelligence & Innovation Research (CAIIRE) is to transform healthcare by harnessing artificial intelligence, driving innovative research, and promoting access to novel technologies.
CAIIRE specializes in five key areas: prediction of postoperative complications, cancer risk prediction, computer vision for surgical analysis, virtual reality interventions for pain management, and predicting lung cancer spread through air spaces.
CAIIRE develops algorithms that utilize biometric data from personal wearable devices to predict postoperative complications in the high-risk weeks following hospital discharge.
Sybil is an AI tool designed to improve early detection of lung cancer by analyzing chest CT scans and estimating the probabilities of lung cancer diagnosis in the next six years.
Computer vision algorithms are being developed to automatically analyze and interpret surgical videos in real-time, aiming to support intra-operative decision-making and identify patients at high risk for postoperative complications.
The virtual reality interventions combine immersive experiences with olfactory stimulation to enhance patient comfort, aiming to reduce pain, anxiety, and improve sleep quality while hospitalized.
STAS is recognized by the WHO and may be linked to worse patient outcomes; however, reliable pre-operative identification methods are still lacking, which CAIIRE aims to address through innovative models.
Dr. Chi-Fu Jeffrey Yang, a thoracic surgeon and the Founding Director of CAIIRE, leads several clinical studies focusing on postoperative complications and lung cancer screening, backed by significant funding.
Arian Mansur is a medical student and serves as the Program Director at CAIIRE, focusing on transforming surgery with AI and conducting clinical research on patient outcomes and quality of care.
Soneesh Kothagundla leads research initiatives at CAIIRE aimed at improving early disease detection and patient outcomes through AI, including large-scale initiatives with the American Lung Cancer Screening Initiative.